A prostate cancer clinical trial conjures up many images and questions in the minds of prostate cancer patients. Questions include – Will I be a guinea pig? Will I be safe? What are the risks and what are the potential gains? So what are the benefits and disadvantages of participating in a clinical trial? It is fair to say that without clinical trials, the development of prostate cancer treatments would be severely limited. Indeed it is well attested that the majority of the population do approve of the use of clinical trials to test and develop new cancer treatments. However, few people are willing to undergo a clinical trial themselves. In the United Kingdom for example, only 5% of cancer patients are willing to be treated within the context of a clinical trial, and for prostate cancer patients the figure is unfortunately considerably lower than this.
– Benefits of participation
o Immediate benefits (i.e. to the trial participants)
As a general overview, patients benefit from participating within a clinical trial, almost regardless of what the particular trial entails. A number of studies have indicated this, having looked at the quality of care received, and the survival of patients who have been treated within the context of a randomized trial. Patients tend to receive both a better quality of care during the trial period, and a longer period of survival when compared to patients who have not participated within such a trial. There could be numerous reasons for this actipotens reviews. A particular factor being that hospitals that participate within the trial process do as a general rule have a very high standard of clinical practice.
In addition, patients within the trail process tend to be monitored much more closely, and develop a closer relationship with the clinical staff, than patients who are treated in a more routine management programme, outside of a trial setting Longer Term Benefits (i.e. to mankind) Clinical trials are obviously formulated following considerable due care and consideration. They aim to address some of the more difficult and urgent medical issues that present for example in the treatment of prostate cancer. Prostate cancer is a particularly challenging area of medicine, and participation in clinical trials can provide valuable learning for future treatment.